Saturday 17 October 2026 Export SENS’s income statement to Excel — free account

Senseonics Holdings, Inc.

Senseonics Holdings, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $35.3 million, up 56.9% from fiscal 2024. In the quarter to June 2026, revenue grew 117.8%, EPS fell 57.5%, free cash flow fell 223.2% and total debt rose 58.4%, each against the same quarter a year earlier. Revenue growth for five consecutive years; insiders bought in the last twelve months.

7.85 0.38 −4.62%

Follow SENS

Alert me

Market cap: $435.2M
P/E: 0.0×
Fwd P/E: −2.7×
Dividend yield: —
F-score: 5/9
Altman Z: −9.78
Beneish M: −2.62
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

Insider Decisions trades per month

Total buys 0.74

Totals in millions of $.

	Dec 25			Mar 26			Jun 26			Sep 26
Buy	4	—	—	—	2	—	1	—	—	1	—	—
Sell	—	—	—	—	—	—	—	—	—	—	—	—

Insider Ownership 19.49%

Capital & Financial Ratios $m

Market Cap 435.15

Revenue 48.55

Net Income (109.39)

Free Cash Flow (96.83)

Net Debt (87.17)

Current Ratio 6.74

Debt/Equity 0.62

P/E ratio 0.00

Fwd P/E (2.72)

P/S ratio 9.35

P/B ratio 5.03

Past 5Y EPS Growth —

This Y EPS Growth (37.51%)

Next Y EPS Growth 15.63%

Next Y revenue growth 82.20%

Next 5Y EPS Growth 2.71%

Green and red mark values outside typical ranges. How we judge →

Valuation vs history

EV/Sales, ten years

P/S against its own 10 years 16.96%

10-year low 10-year high

P/B against its own 10 years 14.93%

10-year low 10-year high

EV/Sales against its own 10 years 10.04%

10-year low 10-year high

Dividends

Payout Ratio —

Annual Dividend Rate —

Annual Dividend Yield —

	total	individual payouts
2025	Powerpack
2024	Powerpack
2023	Powerpack
2022	Powerpack
2021	Powerpack
2020	Powerpack
2019	Powerpack
2018	Powerpack
2017	Powerpack

predictions special payouts not included in total or ratios

Assets vs Liabilities $m

	2023	2024	2025	Q'26
Cash	109	75	94	143
Receivables	5	6	12	10
Inventory	9	4	7	8
Other	—	—	—	—
	130	91	118	166

	2023	2024	2025	Q'26
Payables	5	3	4	5
ST’ Debt	—	—	—	—
Other	—	—	—	—
	17	39	24	25

Compound Annual Growth %

	10y	5y	3y
Sales	98.04%	48.10%	29.09%
Cash Flow	0.00%	0.00%	0.00%
Earnings	0.00%	0.00%	0.00%
Book Value	0.00%	0.00%	0.00%

Revenue $m

	Mar	Jun	Sep	Dec	Year
’26	12	14	—	—	—
’25	6	7	8	14	35
’24	5	5	4	8	22
’23	4	4	6	8	22
’22	2	4	5	6	16
’21	3	3	4	4	14
’20	0	0	1	4	5

Fiscal quarters ending in the months shown.

Operating Cash Flow $m

	Mar	Jun	Sep	Dec	Year
’26	(32)	(30)	—	—	—
’25	(16)	(9)	(16)	(18)	(59)
’24	(20)	(11)	(15)	(14)	(60)
’23	(20)	(18)	(17)	(15)	(70)
’22	(20)	(14)	(15)	(17)	(66)
’21	(16)	(14)	(14)	(12)	(56)
’20	(29)	(17)	(13)	(8)	(67)

Fiscal quarters ending in the months shown.

Free Cash Flow $m

	Mar	Jun	Sep	Dec	Year
’26	(32)	(30)	—	—	—
’25	(17)	(9)	(16)	(18)	(60)
’24	(21)	(13)	(15)	(14)	(63)
’23	(20)	(18)	(17)	(15)	(71)
’22	(20)	(14)	(15)	(17)	(67)
’21	(16)	(14)	(14)	(12)	(56)
’20	(29)	(17)	(13)	(8)	(68)

Fiscal quarters ending in the months shown.

EPS $

	Mar	Jun	Sep	Dec	Year
’26	(0.71)	(0.63)	—	—	—
’25	(0.40)	(0.40)	(0.43)	(0.46)	(1.66)
’24	(0.60)	(0.60)	(0.80)	(0.40)	(2.40)
’23	0.05	(0.80)	(0.80)	(0.60)	(2.20)
’22	2.87	3.47	(2.60)	(0.20)	4.60
’21	(13.60)	(8.40)	1.60	3.80	(14.40)
’20	(4.20)	(0.60)	(2.00)	(8.20)	(15.40)

Fiscal quarters ending in the months shown.

Group	Line	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025	2026e
Price, $
Price, $	Low	43.40	25.20	45.20	16.00	7.00	16.62	15.40	9.22	5.00	5.25	Analyst estimates 2026–2028 Powerpack
	High	84.80	73.40	105.80	67.40	35.60	111.20	77.80	25.40	15.00	28.00
People
People	Employees	58	94	192	191	82	89	121	132	117	130
	Revenue/emp, $m	0.01	0.07	0.10	0.11	0.06	0.15	0.14	0.17	0.19	0.27
Income, $m
Income, $m	Revenue	0	6	19	21	5	14	16	22	22	35
	Gross margin, %	(98.80)	(53.11)	(43.07)	(91.30)	(350.90)	(5.93)	16.63	13.81	2.37	44.71
	EBT	(44)	(59)	(94)	(116)	(175)	(302)	142	(60)	(79)	(69)
	EBT margin, %	(13,231.93)	(927.37)	(496.86)	(542.46)	(3,539.46)	(2,211.88)	867.16	(269.73)	(349.84)	(196.03)
	Net income	(44)	(59)	(94)	(116)	(175)	(302)	142	(60)	(79)	(69)
	Depreciation	0	0	0	1	1	1	1	1	1	2
Per share, $
Per share, $	Revenue	0.07	1.10	2.40	2.26	0.43	0.65	0.70	0.79	0.71	0.84
	Earnings	(9.80)	(10.20)	(12.00)	(12.20)	(15.40)	(14.40)	6.00	(2.20)	(2.40)	(1.66)
	Cash flow	(8.52)	(9.61)	(11.53)	(14.42)	(5.92)	(2.66)	(2.83)	(2.47)	(1.92)	(1.42)
	Capex	(0.11)	(0.06)	(0.13)	(0.11)	(0.02)	(0.01)	(0.01)	(0.01)	(0.07)	(0.03)
	Free cash flow	(8.63)	(9.67)	(11.66)	(14.53)	(5.93)	(2.67)	(2.85)	(2.48)	(1.99)	(1.44)
	Book value	(1.09)	1.25	9.05	(0.92)	(12.64)	(8.79)	(0.11)	1.26	(0.53)	1.46
	Shares, m	4	6	8	9	11	21	23	28	31	42
Valuation, ×
Valuation, ×	P/E	0.00	0.00	0.00	0.00	0.00	0.00	3.43	0.00	0.00	0.00
	P/S	733.84	49.13	21.56	8.12	40.16	82.46	29.41	14.21	14.66	6.53
	P/B	0.00	43.09	5.72	0.00	0.00	0.00	0.00	8.89	0.00	3.77
	EV/Sales	718.30	45.68	17.92	9.04	48.69	77.54	25.78	12.41	14.12	5.66
	EV/FCF	(6.19)	(5.19)	(3.69)	(1.40)	(3.56)	(18.84)	(6.34)	(3.94)	(5.06)	(3.31)
Cash, $m
Cash, $m	Operating cash flow	(38)	(56)	(91)	(136)	(67)	(56)	(66)	(70)	(60)	(59)
	Capex	0	0	(1)	(1)	0	0	0	0	(2)	(1)
	Free cash flow	(38)	(56)	(92)	(137)	(68)	(56)	(67)	(71)	(63)	(60)
Balance, $m
Balance, $m	Working capital	10	22	129	1	14	126	130	113	53	93
	Total debt	19	24	68	116	60	63	56	41	35	36
	Net debt	(1)	(12)	(69)	20	42	(67)	(88)	(68)	(40)	(59)
	Shareholders’ equity	(5)	7	71	(9)	(144)	(186)	(3)	36	(17)	61
Returns, %
Returns, %	ROA	(317.25)	(173.28)	(91.27)	(78.93)	(207.64)	(257.59)	75.47	(38.24)	(65.88)	(60.97)
	ROIC	0.00	0.00	(2,238.70)	(742.40)	0.00	0.00	0.00	0.00	0.00	(1,867.54)
	ROE	602.85	(4,945.69)	(239.33)	(369.10)	229.38	183.53	(151.10)	(363.59)	(817.17)	(310.68)

Negative figures in brackets.

All 10 years →

Fiscal years to Dec 2025 · latest quarter Jun 2026

Charts ten years each

Company	Market cap	P/E	Fwd P/E	Revenue growth (Q)	EPS growth (Q)	FCF growth (Q)	Gross margin (Q)	EBIT margin (Q)	Compare
MASS 908 Devices Inc.	$491.5M	— (loss-making)	— (loss-making)	+23.31% (above 0%: growing)	n/m	+150.95% (above 0%: growing)	51.90%	(79.69%)	Compare
SGHT Sight Sciences, Inc.	$484.8M	— (loss-making)	— (loss-making)	+19.55% (above 0%: growing)	n/m	+26.71% (above 0%: growing)	91.39%	(16.62%)	Compare
BWAY Brainsway Ltd. Sponsored ADR	$475.8M	24.8×	— (loss-making)	+35.43% (above 0%: growing)	+40.00% (above 0%: growing)	−51.68% (below 0%: shrinking)	74.62%	13.98%	Compare
CERS Cerus Corporation	$455.5M	— (loss-making)	— (loss-making)	+5.28% (above 0%: growing)	n/m	−20.90% (below 0%: shrinking)	55.91%	(2.94%)	Compare
NPCE NeuroPace, Inc.	$438.7M	— (loss-making)	— (loss-making)	+17.05% (above 0%: growing)	n/m	−78.70% (below 0%: shrinking)	82.83%	(22.53%)	Compare
SENS Senseonics Holdings, Inc.	$435.2M	— (loss-making)	— (loss-making)	+117.82% (above 0%: growing)	n/m	−223.24% (below 0%: shrinking)	59.10%	(248.48%)
OFIX ORTHOFIX MEDICAL INC.	$390.6M	— (loss-making)	— (loss-making)	+3.85% (above 0%: growing)	n/m	−516.58% (below 0%: shrinking)	70.97%	(3.86%)	Compare
SI Shoulder Innovations, Inc.	$382.4M	— (loss-making)	— (loss-making)	+55.95% (above 0%: growing)	n/m	−52.42% (below 0%: shrinking)	78.26%	(58.43%)	Compare
VMD Viemed Healthcare, Inc.	$371.4M	24.9×	21.9×	+23.85% (above 0%: growing)	−12.50% (below 0%: shrinking)	−18.15% (below 0%: shrinking)	57.68%	6.39%	Compare
Median of peers	$447.1M	—	—	+21.43%	—	−36.29%	72.80%	(10.24%)

All 149 Medical Devices stocks →